AR060162A1 - Derivado de 4-oxoquinolina. composicion farmaceutica y uso como antibacteriano - Google Patents

Derivado de 4-oxoquinolina. composicion farmaceutica y uso como antibacteriano

Info

Publication number
AR060162A1
AR060162A1 ARP070101276A ARP070101276A AR060162A1 AR 060162 A1 AR060162 A1 AR 060162A1 AR P070101276 A ARP070101276 A AR P070101276A AR P070101276 A ARP070101276 A AR P070101276A AR 060162 A1 AR060162 A1 AR 060162A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
oxoquinoline
antibacterial
derivative
oxoquinolin
Prior art date
Application number
ARP070101276A
Other languages
English (en)
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38540958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR060162(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of AR060162A1 publication Critical patent/AR060162A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Hemihidrato del ácido [7-[(7S)-7-amino-7-metil-5-azaspiro[2,4]heptan-5-il]-6-fluoro-1-[(1R,2S)-2-fluorociclopropil]-8-metoxi-1,4-dihidro-4-oxoquinolin-3-carboxílico. Composicion farmacéutica que lo contiene y uso como agente antiinfeccioso.
ARP070101276A 2006-03-27 2007-03-27 Derivado de 4-oxoquinolina. composicion farmaceutica y uso como antibacteriano AR060162A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006084708 2006-03-27

Publications (1)

Publication Number Publication Date
AR060162A1 true AR060162A1 (es) 2008-05-28

Family

ID=38540958

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070101276A AR060162A1 (es) 2006-03-27 2007-03-27 Derivado de 4-oxoquinolina. composicion farmaceutica y uso como antibacteriano

Country Status (7)

Country Link
US (1) US8003666B2 (es)
EP (1) EP2000467B1 (es)
JP (1) JP5131926B2 (es)
AR (1) AR060162A1 (es)
ES (1) ES2513819T3 (es)
TW (1) TWI386401B (es)
WO (1) WO2007111023A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
AU4467101A (en) * 2000-03-31 2001-10-08 Daiichi Seiyaku Co Quinolonecarboxylic acid derivative
JP2002255962A (ja) * 2001-02-26 2002-09-11 Dai Ichi Seiyaku Co Ltd キノロンカルボン酸誘導体
JPWO2003076428A1 (ja) * 2002-03-08 2005-07-07 第一製薬株式会社 キノロンカルボン酸誘導体
JP2005146386A (ja) 2003-11-18 2005-06-09 Mitsui Mining & Smelting Co Ltd 金属粉スラリーの製造方法及びその製造方法で得られたニッケル粉スラリー
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
JP5017101B2 (ja) * 2005-05-20 2012-09-05 第一三共株式会社 不斉四置換炭素原子含有化合物の製法
US8129533B2 (en) * 2005-09-28 2012-03-06 Dalichi Sankyo Company, Limited Method for production of quinolone-containing lyophilized preparation

Also Published As

Publication number Publication date
TWI386401B (zh) 2013-02-21
JPWO2007111023A1 (ja) 2009-08-06
US20100234410A1 (en) 2010-09-16
EP2000467A4 (en) 2011-03-09
TW200813005A (en) 2008-03-16
ES2513819T3 (es) 2014-10-27
WO2007111023A1 (ja) 2007-10-04
US8003666B2 (en) 2011-08-23
EP2000467B1 (en) 2014-10-01
EP2000467A2 (en) 2008-12-10
JP5131926B2 (ja) 2013-01-30
EP2000467A9 (en) 2009-03-18

Similar Documents

Publication Publication Date Title
SV2009003299A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
HN2009000784A (es) Dihidropirazolonas sustituidas
UY31080A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
BRPI0915084B8 (pt) composto, e, composição farmacêutica
CL2012002771A1 (es) Compuestos derivados de ariletinilo sustituidos, moduladores de los receptores mglur5; proceso de obtencion; composicion farmaceutica; y su uso en el tratamiento o prevencion de la esquizofrenia, enfermedades cognitivas, sindrome de x fragil o el autismo.
BRPI0916286B8 (pt) amidofenóxi-indazóis úteis como inibidores de c-met, seus usos, e composição farmacêutica
SV2011003855A (es) Heteroarilos sustituidos
UY29767A1 (es) Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones
UY29341A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricación
BRPI0917017B8 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
CL2011001331A1 (es) Clorhidrato de nalmefeno dihidratado; métodos para su preparación; composición farmacéutica que lo comprende; y uso para el tratamiento del alcoholismo.
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
CL2009001240A1 (es) Compuestos derivados del acido l-glutamico y l-glutamina marcados con [f-18]; procedimiento de preparacion; composicion farmaceutica que comprende a los compuestos y su uso como agentes en el diagnostico de tumores.
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
BRPI0916571A2 (pt) composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto
HN2011002578A (es) Nuevos derivados de compuestos de [3,2-c]pirazol esteroidal con actividad clucocorticoide.
DOP2006000015A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricación
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
DOP2006000028A (es) Pirroles sustituidos, composiciones que los contienen, proceso de fabricación y utilización
CR20150080A (es) Derivados y analogos de n-etilquinolonas y n-etilazaquinolonas
AR060162A1 (es) Derivado de 4-oxoquinolina. composicion farmaceutica y uso como antibacteriano
AR073086A1 (es) Composicion farmaceutica para el tratamiento de un trastorno de ansiedad que comprende exo-7-(8-h-8-aza-biciclo(3,2,1)oct-3-iloxi)-cromen-2-ona, uso y equipo

Legal Events

Date Code Title Description
FB Suspension of granting procedure